| Nov 18 |
BioCryst Launches ORLADEYO® (berotralstat) in Ireland
|
| Nov 5 |
BioCryst Announces Strong Q3 2024 Revenue Growth
|
| Nov 5 |
BioCryst Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Nov 5 |
Q3 2024 BioCryst Pharmaceuticals Inc Earnings Call
|
| Nov 5 |
BioCryst Pharmaceuticals Inc (BCRX) Q3 2024 Earnings Call Highlights: Strong ORLADEYO Growth ...
|
| Nov 4 |
BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript
|
| Nov 4 |
BioCryst Pharmaceuticals, Inc. (BCRX) Q3 2024 Earnings Call Transcript
|
| Nov 4 |
BioCryst Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Nov 4 |
BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 4 |
BioCryst: Q3 Earnings Snapshot
|
